James C Czirr is > 10% Shareholder of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 1.05 Million shares of GALT, which is worth approximately $2.91 Million. The most recent transaction as insider was on Jun 06, 2025, when has been sold 323,125 shares (Common Stock) at a price of $2.27 per share, resulting in proceeds of $733,493. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.05M
44.73% 3M change
n/a 12M change
Total Value Held $2.91 Million

JAMES C CZIRR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2025
BUY
Exercise of conversion of derivative security
$733,493 $2.27 p/Share
323,125 Added 23.61%
1,045,541 Common Stock
Mar 31 2025
BUY
Other acquisition or disposition
$6,000 $6.0 p/Share
1,000 Added 0.14%
722,416 Common Stock
Feb 04 2025
SELL
Bona fide gift
-
10,000 Reduced 1.37%
721,416 Common Stock
Feb 03 2025
SELL
Bona fide gift
-
10,000 Reduced 1.35%
731,416 Common Stock
JCC

James C Czirr

> 10% Shareholder
Norcross, GA

Track Institutional and Insider Activities on GALT

Follow GALECTIN THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT